A carregar...
A Phase I and Correlative Biology Study of Cilengitide in Patients with Recurrent Malignant Glioma
PURPOSE: This multi-institutional phase I trial was designed to determine the maximum tolerated dose (MTD) of cilengitide (EMD 121974) and evaluate the use of perfusion MRI in patients with recurrent malignant glioma. PATIENTS AND METHODS: Patients received cilengitide twice weekly on a continuous b...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3811028/ https://ncbi.nlm.nih.gov/pubmed/17470857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2006.06.6514 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|